[go: up one dir, main page]

WO2006110726A3 - Preparations pharmaceutiques et procedes de traitement et de prevention - Google Patents

Preparations pharmaceutiques et procedes de traitement et de prevention Download PDF

Info

Publication number
WO2006110726A3
WO2006110726A3 PCT/US2006/013448 US2006013448W WO2006110726A3 WO 2006110726 A3 WO2006110726 A3 WO 2006110726A3 US 2006013448 W US2006013448 W US 2006013448W WO 2006110726 A3 WO2006110726 A3 WO 2006110726A3
Authority
WO
WIPO (PCT)
Prior art keywords
methods
prevention
treatment
dosage formulations
combinations
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/US2006/013448
Other languages
English (en)
Other versions
WO2006110726A2 (fr
Inventor
Eliot H Ohlstein
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Glaxo Group Ltd
Original Assignee
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd
Publication of WO2006110726A2 publication Critical patent/WO2006110726A2/fr
Anticipated expiration legal-status Critical
Publication of WO2006110726A3 publication Critical patent/WO2006110726A3/fr
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • A61K31/5355—Non-condensed oxazines and containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

La présente invention concerne des combinaisons de 4-méthyl-2-oxo-2H-1-benzopyran-7-yl-5-thio-ß-D-xylopyranoside et d'inhibiteurs du facteur Xa, des procédés pour produire ces combinaisons et des procédés pour utiliser ces combinaisons afin de traiter et de prévenir divers troubles thromboemboliques chez les mammifères, en particulier chez l'homme.
PCT/US2006/013448 2005-04-11 2006-04-11 Preparations pharmaceutiques et procedes de traitement et de prevention Ceased WO2006110726A2 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US66998505P 2005-04-11 2005-04-11
US60/669,985 2005-04-11

Publications (2)

Publication Number Publication Date
WO2006110726A2 WO2006110726A2 (fr) 2006-10-19
WO2006110726A3 true WO2006110726A3 (fr) 2009-04-16

Family

ID=37087623

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2006/013448 Ceased WO2006110726A2 (fr) 2005-04-11 2006-04-11 Preparations pharmaceutiques et procedes de traitement et de prevention

Country Status (1)

Country Link
WO (1) WO2006110726A2 (fr)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102012014954A1 (de) 2012-07-30 2014-01-30 Hochschule für angewandte Wissenschaft und Kunst (HAWK) Hildesheim Vorrichtung zum Bestimmen eines Durchmessers eines Baumstammes

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2002100830A1 (fr) * 2001-06-08 2002-12-19 Glaxo Group Limited Derives de pyrrolidine servant d'inhibiteurs du facteur xa
US20020198193A1 (en) * 2001-05-11 2002-12-26 Laboratoires Fournier S.A. Novel 5-thio-B-D-xylopryanoside derivatives, preparation, method, pharmaceutical compositions containing them and their therapeutic use

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20020198193A1 (en) * 2001-05-11 2002-12-26 Laboratoires Fournier S.A. Novel 5-thio-B-D-xylopryanoside derivatives, preparation, method, pharmaceutical compositions containing them and their therapeutic use
WO2002100830A1 (fr) * 2001-06-08 2002-12-19 Glaxo Group Limited Derives de pyrrolidine servant d'inhibiteurs du facteur xa

Also Published As

Publication number Publication date
WO2006110726A2 (fr) 2006-10-19

Similar Documents

Publication Publication Date Title
WO2006003388A8 (fr) Compositions et procedes pour le traitement de troubles inflammatoires
WO2007146965A3 (fr) Composés destinés au traitement d'une maladie périodontale
WO2004078116A3 (fr) Inhibiteurs de la p 38 et leurs procedes d'utilisation
EP2559694A3 (fr) Azaindoles utiles en tant qu'inhibiteurs des kinases Janus
IL193080A0 (en) Methods, compositions, and kits for the treatment of musculoskeletal disorders and symptoms associated therewith
WO2009036175A3 (fr) Inhibiteur de f1f0-atpase et procédés associés
WO2008030367A3 (fr) Inhibiteurs sélectifs de la myostatine
WO2008104306A3 (fr) Amides de 4-aryl-1,4-dihydro-1,6-naphthyridine substitués et utilisation de ceux-ci
WO2006071960A3 (fr) Compositions et procedes de traitement de troubles de la proliferation cellulaire
WO2008076392A3 (fr) Composés utilisables en tant qu'inhibiteurs de protéines kinases
SG151327A1 (en) Deazapurines useful as inhibitors of janus kinases
WO2008033562A3 (fr) Composés inhibiteurs de kinases
WO2010127099A3 (fr) Compositions pharmaceutiques comprenant de l'epa et un agent cardiovasculaire et leurs procédés d'utilisation
WO2008116139A3 (fr) Composés utiles en tant qu'inhibiteurs des kinases de janus
WO2007106537A3 (fr) Aminoquinolones utilisées comme inhibiteurs de la gsk-3
WO2008155069A3 (fr) Oxazolidinones substituées et leur utilisation
WO2006124748A3 (fr) Composes polycycliques et procedes pour les utiliser
WO2006131591A3 (fr) Forme posologique destinee a etre administree par voie orale
WO2008079363A3 (fr) Utilisation de composés à base de tétracycline substituée dans le traitement d'affections cutanées inflammatoires
EP2772260A3 (fr) Compositions thérapeutiques comprenant de l'hyaluronane et des anticorps thérapeutiques ainsi que des procédés de traitement
WO2009035634A3 (fr) Cyanoaminoquinolones et tétrazoloaminoquinolones en tant qu'inhibiteurs de gsk-3
WO2007136741A3 (fr) N-desméthyldoxépine et procédés pour traiter les troubles du sommeil l'utilisant
WO2007050793A3 (fr) Methodes et compositions de traitement du syndrome de marfan et de troubles associes
WO2009009034A3 (fr) Procédées et compositions utiles dans le traitement de la mucosite
WO2006116221A3 (fr) Nouvelles combinaisons therapeutiques pour le traitement ou la prevention de troubles psychotiques

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application
NENP Non-entry into the national phase

Ref country code: DE

NENP Non-entry into the national phase

Ref country code: RU

122 Ep: pct application non-entry in european phase

Ref document number: 06749733

Country of ref document: EP

Kind code of ref document: A2